Morgan C Lyon1,2,3, Courtney Foster4, Xinhong Ding5, Sharmila Dorbala4,6, Don Spence5, Manojeet Bhattacharya5, A Hans Vija5, Marcelo F DiCarli4,6, Stephen C Moore4,6. 1. Division of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA. mlyon@invicro.com. 2. Department of Radiology, Harvard Medical School, Boston, MA, USA. mlyon@invicro.com. 3. inviCRO, 27 Drydock Ave, Boston, MA, 02210, USA. mlyon@invicro.com. 4. Division of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA. 5. Molecular Imaging, Siemens Medical Solutions USA, Inc., Hoffman Estates, IL, USA. 6. Department of Radiology, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Recent technological advances in myocardial perfusion imaging may warrant the use of lower injected activity. We evaluated whether quantitative measures of stress myocardial perfusion defects using Tc-99m sestamibi and low-energy high-resolution (LEHR) collimators are equivalent to lower dose SPECT-CT with cardiac multifocal collimators and software (IQ·SPECT). METHODS:93 patients underwentone-day rest-stress gated SPECT-CT. Following conventional rest imaging, 925-1100 MBq (25-30 mCi) of Tc-99m sestamibi was injected during stress testing. Stress SPECT-CT images were acquired two ways: with LEHR (13 minutes) and IQ·SPECT (7 minutes). Low-dose IQ·SPECT stress was simulated by subsampling the full-dose data to half-, quarter-, and eighth-count levels. Abnormalities were quantified using the total perfusion deficit (TPD) score and dose-specific databases. RESULTS: The mean ± SD of the differences between LEHR and IQ·SPECT TPD scores were -1.01 ± 5.36%, -0.10 ± 5.81%, 1.78 ± 4.81%, and 1.75 ± 6.05% at full, half, quarter, and eighth doses, respectively. Differences were statistically significant for quarter and eighth doses. Correlation between LEHR and IQ·SPECT was excellent at all doses (R ≥ 0.93). Bland-Altman plots demonstrated minimal bias. CONCLUSIONS: With IQ·SPECT, quantitative stress SPECT-CT imaging is possible with half of the standard injected activity in half the time.
RCT Entities:
BACKGROUND: Recent technological advances in myocardial perfusion imaging may warrant the use of lower injected activity. We evaluated whether quantitative measures of stress myocardial perfusion defects using Tc-99m sestamibi and low-energy high-resolution (LEHR) collimators are equivalent to lower dose SPECT-CT with cardiac multifocal collimators and software (IQ·SPECT). METHODS: 93 patients underwent one-day rest-stress gated SPECT-CT. Following conventional rest imaging, 925-1100 MBq (25-30 mCi) of Tc-99m sestamibi was injected during stress testing. Stress SPECT-CT images were acquired two ways: with LEHR (13 minutes) and IQ·SPECT (7 minutes). Low-dose IQ·SPECT stress was simulated by subsampling the full-dose data to half-, quarter-, and eighth-count levels. Abnormalities were quantified using the total perfusion deficit (TPD) score and dose-specific databases. RESULTS: The mean ± SD of the differences between LEHR and IQ·SPECT TPD scores were -1.01 ± 5.36%, -0.10 ± 5.81%, 1.78 ± 4.81%, and 1.75 ± 6.05% at full, half, quarter, and eighth doses, respectively. Differences were statistically significant for quarter and eighth doses. Correlation between LEHR and IQ·SPECT was excellent at all doses (R ≥ 0.93). Bland-Altman plots demonstrated minimal bias. CONCLUSIONS: With IQ·SPECT, quantitative stress SPECT-CT imaging is possible with half of the standard injected activity in half the time.
Authors: Martin Havel; Michal Kolacek; Milan Kaminek; Vladimir Dedek; Otakar Kraft; Pavel Sirucek Journal: Hell J Nucl Med Date: 2014 Sep-Dec Impact factor: 1.102
Authors: Federico Caobelli; Stefano Ren Kaiser; James T Thackeray; Frank M Bengel; Matteo Chieregato; Alberto Soffientini; Claudio Pizzocaro; Giordano Savelli; Marco Galelli; Ugo Paolo Guerra Journal: J Nucl Med Date: 2014-11-20 Impact factor: 10.057
Authors: Andrew J Einstein; Lynne L Johnson; Albert J DeLuca; Andrew C Kontak; Daniel W Groves; Jennifer Stant; Ted Pozniakoff; Bin Cheng; LeRoy E Rabbani; Sabahat Bokhari Journal: J Nucl Med Date: 2015-03-05 Impact factor: 10.057
Authors: Jersey Chen; Andrew J Einstein; Reza Fazel; Harlan M Krumholz; Yongfei Wang; Joseph S Ross; Henry H Ting; Nilay D Shah; Khurram Nasir; Brahmajee K Nallamothu Journal: J Am Coll Cardiol Date: 2010-07-09 Impact factor: 24.094
Authors: Edward M Hsiao; Xinhua Cao; David Zurakowski; Katherine A Zukotynski; Laura A Drubach; Frederick D Grant; Amos Yahil; A Hans Vija; Royal T Davis; Frederic H Fahey; S Ted Treves Journal: Radiology Date: 2011-09-07 Impact factor: 11.105
Authors: Reza Fazel; Harlan M Krumholz; Yongfei Wang; Joseph S Ross; Jersey Chen; Henry H Ting; Nilay D Shah; Khurram Nasir; Andrew J Einstein; Brahmajee K Nallamothu Journal: N Engl J Med Date: 2009-08-27 Impact factor: 91.245
Authors: Sharmila Dorbala; Karthik Ananthasubramaniam; Ian S Armstrong; Panithaya Chareonthaitawee; E Gordon DePuey; Andrew J Einstein; Robert J Gropler; Thomas A Holly; John J Mahmarian; Mi-Ae Park; Donna M Polk; Raymond Russell; Piotr J Slomka; Randall C Thompson; R Glenn Wells Journal: J Nucl Cardiol Date: 2018-10 Impact factor: 5.952
Authors: Brian G Abbott; James A Case; Sharmila Dorbala; Andrew J Einstein; James R Galt; Robert Pagnanelli; Renée P Bullock-Palmer; Prem Soman; R Glenn Wells Journal: J Nucl Cardiol Date: 2018-10 Impact factor: 5.952
Authors: Firas J Al Badarin; John A Spertus; Timothy M Bateman; Krishna K Patel; Eric V Burgett; Kevin F Kennedy; Randall C Thompson Journal: J Nucl Cardiol Date: 2019-01-31 Impact factor: 5.952
Authors: Albert Juan Ramon; Yongyi Yang; P Hendrik Pretorius; Karen L Johnson; Michael A King; Miles N Wernick Journal: IEEE Trans Med Imaging Date: 2020-03-10 Impact factor: 11.037